{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:28:00Z","timestamp":1793730480811,"version":"4.6.1"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.neurobiolaging.2018.01.019","type":"journal-article","created":{"date-parts":[[2018,2,5]],"date-time":"2018-02-05T12:34:45Z","timestamp":1517834085000},"page":"217-234","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Identification of new PDE9A isoforms and how their expression and\u00a0subcellular compartmentalization in the brain change across the life span"],"prefix":"10.1016","volume":"65","author":[{"given":"Neema S.","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Klett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katy","family":"Pilarzyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong ik","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank S.","family":"Menniti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michy P.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2018.01.019_bib1","doi-asserted-by":"crossref","first-page":"e901","DOI":"10.1038\/tp.2016.174","article-title":"Reversal of neurobehavioral social deficits in dystrophic mice using inhibitors of phosphodiesterases pde5a and pde9a","volume":"6","author":"Alexander","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2018.01.019_bib2","doi-asserted-by":"crossref","first-page":"9068","DOI":"10.1523\/JNEUROSCI.21-22-09068.2001","article-title":"Expression of cgmp-specific phosphodiesterase 9a mrna in the rat brain","volume":"21","author":"Andreeva","year":"2001","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2018.01.019_bib3","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1006\/nbdi.2002.0492","article-title":"Beta-amyloid peptides decrease soluble guanylyl cyclase expression in astroglial cells","volume":"10","author":"Baltrons","year":"2002","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neurobiolaging.2018.01.019_bib4","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.nbd.2004.07.022","article-title":"Reduced expression of no-sensitive guanylyl cyclase in reactive astrocytes of Alzheimer disease, Creutzfeldt-Jakob disease, and multiple sclerosis brains","volume":"17","author":"Baltrons","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neurobiolaging.2018.01.019_bib5","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.bbrc.2006.08.180","article-title":"Profiling human phosphodiesterase genes and splice isoforms","volume":"350","author":"Bingham","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neurobiolaging.2018.01.019_bib6","doi-asserted-by":"crossref","first-page":"e2569","DOI":"10.1002\/hup.2569","article-title":"A\u00a0phase i, randomized, proof-of-clinical-mechanism study assessing the pharmacokinetics and pharmacodynamics of the oral pde9a inhibitor bi 409306 in healthy male volunteers","volume":"32","author":"Boland","year":"2017","journal-title":"Human Psychopharmacol. Clin. Exp."},{"key":"10.1016\/j.neurobiolaging.2018.01.019_bib7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0304-3940(95)11323-O","article-title":"Reduced nitric oxide responsive soluble guanylyl cyclase activity in the superior temporal cortex of patients with Alzheimer's disease","volume":"187","author":"Bonkale","year":"1995","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neurobiolaging.2018.01.019_bib8","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1161\/CIRCULATIONAHA.105.599241","article-title":"Cyclic guanosine monophosphate compartmentation in rat cardiac myocytes","volume":"113","author":"Castro","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.neurobiolaging.2018.01.019_bib9","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1146\/annurev.biochem.76.060305.150444","article-title":"Biochemistry and physiology of cyclic nucleotide phosphodiesterases: Essential components in cyclic nucleotide signaling","volume":"76","author":"Conti","year":"2007","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.neurobiolaging.2018.01.019_bib10","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s12311-010-0156-y","article-title":"Neurofilament heavy chain expression reveals a unique parasagittal stripe topography in the mouse cerebellum","volume":"10","author":"Demilly","year":"2011","journal-title":"Cerebellum"},{"key":"10.1016\/j.neurobiolaging.2018.01.019_bib11","doi-asserted-by":"crossref","first-page":"15559","DOI":"10.1074\/jbc.273.25.15559","article-title":"Isolation and characterization of pde9a, a novel human cgmp-specific phosphodiesterase","volume":"273","author":"Fisher","year":"1998","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2018.01.019_bib12","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1152\/physrev.00030.2010","article-title":"Mammalian cyclic nucleotide phosphodiesterases: molecular mechanisms and physiological functions","volume":"91","author":"Francis","year":"2011","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neurobiolaging.2018.01.019_bib13","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.neuroscience.2008.12.037","article-title":"Influence of parallel fiber-Purkinje cell synapse formation on postnatal development of climbing fiber-Purkinje cell synapses in the cerebellum","volume":"162","author":"Hashimoto","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurobiolaging.2018.01.019_bib14","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1038\/npp.2016.106","article-title":"Phosphodiesterase 11a (pde11a), enriched in ventral hippocampus neurons, is required for consolidation of social but not nonsocial memories in mice","volume":"41","author":"Hegde","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neurobiolaging.2018.01.019_bib15","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.neuroscience.2016.08.019","article-title":"Pde11a regulates social behaviors and is a key mechanism by which social experience sculpts the brain","volume":"335","author":"Hegde","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurobiolaging.2018.01.019_bib16","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.tibs.2009.09.007","article-title":"Underpinning compartmentalised camp signalling through targeted camp breakdown","volume":"35","author":"Houslay","year":"2010","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.neurobiolaging.2018.01.019_bib17","doi-asserted-by":"crossref","first-page":"9624","DOI":"10.1073\/pnas.0401120101","article-title":"Crystal structure of phosphodiesterase 9 shows orientation variation of inhibitor 3-isobutyl-1-methylxanthine binding","volume":"101","author":"Huai","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2018.01.019_bib18","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.neuropharm.2011.05.009","volume":"61","author":"Hutson","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neurobiolaging.2018.01.019_bib19","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.1046\/j.1432-1033.2003.03808.x","article-title":"Dimerization and oligomerization of the chaperone calreticulin","volume":"270","author":"Jorgensen","year":"2003","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.neurobiolaging.2018.01.019_bib20","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.pbb.2009.03.003","article-title":"The supra-additive hyperactivity caused by an amphetamine-chlordiazepoxide mixture exhibits an inverted-u dose response: negative implications for the use of a model in screening for mood stabilizers","volume":"92","author":"Kelly","year":"2009","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neurobiolaging.2018.01.019_bib21","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.cellsig.2013.10.007","article-title":"Select 3',5'-cyclic nucleotide phosphodiesterases exhibit altered expression in the aged rodent brain","volume":"26","author":"Kelly","year":"2014","journal-title":"Cell Signal"},{"key":"10.1016\/j.neurobiolaging.2018.01.019_bib22","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cellsig.2017.11.004","article-title":"Cyclic nucleotide signaling changes associated with normal aging and age-related diseases of the brain","volume":"42","author":"Kelly","year":"2018","journal-title":"Cell Signal"},{"key":"10.1016\/j.neurobiolaging.2018.01.019_bib23","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1124\/jpet.111.191353","article-title":"Phosphodiesterase 9a regulates central cgmp and modulates responses to cholinergic and monoaminergic perturbation in\u00a0vivo","volume":"341","author":"Kleiman","year":"2012","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neurobiolaging.2018.01.019_bib24","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1146\/annurev-pharmtox-010716-104756","article-title":"Nanodomain regulation of cardiac cyclic nucleotide signaling by phosphodiesterases","volume":"57","author":"Kokkonen","year":"2017","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.neurobiolaging.2018.01.019_bib26","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/j.neuropharm.2011.12.021","article-title":"Inhibition of acetylcholinesterase and phosphodiesterase-9a has differential effects on hippocampal early and late ltp","volume":"62","author":"Kroker","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neurobiolaging.2018.01.019_bib27","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1016\/j.neurobiolaging.2014.03.023","article-title":"Pde9a inhibition rescues amyloid beta-induced deficits in synaptic plasticity and cognition","volume":"35","author":"Kroker","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2018.01.019_bib28","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.neuropharm.2010.05.004","article-title":"Quantitative comparison of phosphodiesterase mrna distribution in human brain and peripheral tissues","volume":"59","author":"Lakics","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neurobiolaging.2018.01.019_bib29","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nature14332","article-title":"Phosphodiesterase 9a controls nitric-oxide-independent cgmp and hypertrophic heart disease","volume":"519","author":"Lee","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2018.01.019_bib30","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1177\/0269881112447991","article-title":"The effect of phosphodiesterase inhibitors on the extinction of cocaine-induced conditioned place preference in mice","volume":"26","author":"Liddie","year":"2012","journal-title":"J.\u00a0Psychopharmacol."},{"key":"10.1016\/j.neurobiolaging.2018.01.019_bib31","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.pharmthera.2005.07.003","article-title":"Cyclic nucleotide phosphodiesterase (pde) superfamily: a new target for the development of specific therapeutic agents","volume":"109","author":"Lugnier","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neurobiolaging.2018.01.019_bib32","doi-asserted-by":"crossref","first-page":"e742","DOI":"10.1038\/tp.2016.3","article-title":"Novel, primate-specific pde10a isoform highlights gene expression complexity in human striatum with implications on the molecular pathology of bipolar disorder","volume":"6","author":"MacMullen","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2018.01.019_bib33","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.gene.2016.12.033","article-title":"Novel pde10a transcript diversity in the human striatum: Insights into gene complexity, conservation and regulation","volume":"606","author":"MacMullen","year":"2017","journal-title":"Gene"},{"key":"10.1016\/j.neurobiolaging.2018.01.019_bib34","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nrd2058","article-title":"Phosphodiesterases in the cns: targets for drug development","volume":"5","author":"Menniti","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neurobiolaging.2018.01.019_bib35","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/nature13185","article-title":"Transcriptional landscape of the prenatal human brain","volume":"508","author":"Miller","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2018.01.019_bib36","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.expneurol.2014.10.001","article-title":"Application of neurophysiological biomarkers for Huntington's disease: evaluating a phosphodiesterase 9a inhibitor","volume":"263","author":"Nagy","year":"2015","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2018.01.019_bib37","doi-asserted-by":"crossref","first-page":"P330","DOI":"10.1016\/j.jalz.2009.04.553","article-title":"Pf-04447943, a novel pde9a inhibitor, increases cgmp levels in cerebrospinal fluid: translation from non-clinical species to healthy human volunteers","volume":"5","author":"Nicholas","year":"2009","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.neurobiolaging.2018.01.019_bib38","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.neuropharm.2015.04.026","article-title":"Amphetamine sensitization in mice is sufficient to produce both manic- and depressive-related behaviors as well as changes in the functional connectivity of corticolimbic structures","volume":"95","author":"Pathak","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neurobiolaging.2018.01.019_bib39","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1038\/mp.2016.155","article-title":"Pde11a negatively regulates lithium responsivity","volume":"22","author":"Pathak","year":"2017","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2018.01.019_bib40","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S0006-291X(03)00021-4","article-title":"Identification and distribution of different mrna variants produced by differential splicing in the human phosphodiesterase 9a gene","volume":"301","author":"Rentero","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neurobiolaging.2018.01.019_bib41","doi-asserted-by":"crossref","first-page":"P331","DOI":"10.1016\/j.jalz.2009.04.554","article-title":"Pde9a-mediated regulation of cgmp: developing a biomarker for a novel therapy for Alzheimer's disease","volume":"5","author":"Schmidt","year":"2009","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.neurobiolaging.2018.01.019_bib42","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2174\/1567205011666140505100858","article-title":"A\u00a0multicenter, double-blind, placebo-controlled trial of the pde9a inhibitor, pf-04447943, in Alzheimer's disease","volume":"11","author":"Schwam","year":"2014","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.neurobiolaging.2018.01.019_bib43","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1146\/annurev.cellbio.23.090506.123237","article-title":"Morphology, molecular codes, and circuitry produce the three-dimensional complexity of the cerebellum","volume":"23","author":"Sillitoe","year":"2007","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.neurobiolaging.2018.01.019_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lfs.2014.04.007","article-title":"Phosphodiesterase 9: Insights from protein structure and role in therapeutics","volume":"106","author":"Singh","year":"2014","journal-title":"Life Sci."},{"key":"10.1016\/j.neurobiolaging.2018.01.019_bib45","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0021-9258(19)45623-8","article-title":"Radioimmunoassay for cyclic nucleotides. 3. Effect of ischemia, changes during development and regional distribution of adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate in mouse brain","volume":"247","author":"Steiner","year":"1972","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2018.01.019_bib46","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.neuropharm.2008.07.005","article-title":"The novel selective pde9 inhibitor bay 73-6691 improves learning and memory in rodents","volume":"55","author":"van der Staay","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neurobiolaging.2018.01.019_bib47","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1023\/A:1025704031210","article-title":"Cloning and localization of the cgmp-specific phosphodiesterase type 9 in the rat brain","volume":"31","author":"van Staveren","year":"2002","journal-title":"J.\u00a0Neurocytol."},{"key":"10.1016\/j.neurobiolaging.2018.01.019_bib48","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/cne.10955","article-title":"Mrna expression patterns of the cgmp-hydrolyzing phosphodiesterases types 2, 5, and 9 during development of the rat brain","volume":"467","author":"Van Staveren","year":"2003","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2018.01.019_bib49","first-page":"75","article-title":"Localization of cyclic guanosine 3',5'-monophosphate-hydrolyzing phosphodiesterase type 9 in rat brain by nonradioactive in situ hydridization","volume":"307","author":"van Staveren","year":"2005","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.neurobiolaging.2018.01.019_bib50","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3109\/01677063.2011.630494","article-title":"The selective phosphodiesterase 9 (pde9) inhibitor pf-04447943 attenuates a scopolamine-induced deficit in a novel rodent attention task","volume":"25","author":"Vardigan","year":"2011","journal-title":"J.\u00a0Neurogenet."},{"key":"10.1016\/j.neurobiolaging.2018.01.019_bib51","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0378-1119(03)00733-9","article-title":"Identification and characterization of a new human type 9 cgmp-specific phosphodiesterase splice variant (pde9a5). Differential tissue distribution and subcellular localization of pde9a variants","volume":"314","author":"Wang","year":"2003","journal-title":"Gene"},{"key":"10.1016\/j.neurobiolaging.2018.01.019_bib52","doi-asserted-by":"crossref","first-page":"P820","DOI":"10.1016\/j.jalz.2016.06.1666","article-title":"Study design and characteristics of two phase ii proof-of-concept clinical trials of the pde9 inhibitor bi 409306 in early Alzheimer's disease","volume":"12","author":"Wunderlich","year":"2016","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.neurobiolaging.2018.01.019_bib53","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cell.2016.01.029","article-title":"Widespread expansion of protein interaction capabilities by alternative splicing","volume":"164","author":"Yang","year":"2016","journal-title":"Cell."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458018300344?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458018300344?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T18:56:42Z","timestamp":1660417002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458018300344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":52,"alternative-id":["S0197458018300344"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2018.01.019","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of new PDE9A isoforms and how their expression and\u00a0subcellular compartmentalization in the brain change across the life span","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2018.01.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}